Bausch Health Companies annual ebitda margin
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Bausch Health Companies EBITDA Margin Growth & History (BHC)
Bausch Health Companies's ebitda margin was 29.43% for fiscal 2025.
View full Bausch Health Companies company overviewBausch Health Companies annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 29.43% | +0.20 pp |
| 2024 | 2024-12-31 | 29.23% | +3.79 pp |
| 2023 | 2023-12-31 | 25.43% | +2.68 pp |
| 2022 | 2022-12-31 | 22.75% | −0.99 pp |
| 2021 | 2021-12-31 | 23.74% | −7.42 pp |
| 2020 | 2020-12-31 | 31.16% | +9.39 pp |
| 2019 | 2019-12-31 | 21.76% | +16.57 pp |
| 2018 | 2018-12-31 | 5.19% | −28.74 pp |
| 2017 | 2017-12-31 | 33.93% | +10.15 pp |
| 2016 | 2016-12-31 | 23.78% | −14.46 pp |
| 2015 | 2015-12-31 | 38.23% | −5.82 pp |
| 2014 | 2014-12-31 | 44.05% | +16.21 pp |
| 2013 | 2013-12-31 | 27.84% | −2.79 pp |
| 2012 | 2012-12-31 | 30.63% | −6.97 pp |
| 2011 | 2011-12-31 | 37.59% | +25.37 pp |
| 2010 | 2010-12-31 | 12.23% | −28.05 pp |
| 2009 | 2009-12-31 | 40.27% | — |
Bausch Health Companies quarterly ebitda margin
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 35.80% | +6.12 pp |
| Q1 2026 | 2026-03-31 | −25.95% | −51.67 pp |
| Q4 2025 | 2025-12-31 | 27.32% | −6.48 pp |
| Q3 2025 | 2025-09-30 | 34.50% | +9.00 pp |
| Q2 2025 | 2025-06-30 | 29.68% | +0.26 pp |
| Q1 2025 | 2025-03-31 | 25.72% | −2.20 pp |
| Q4 2024 | 2024-12-31 | 33.80% | +5.11 pp |
| Q3 2024 | 2024-09-30 | 25.50% | +11.42 pp |
| Q2 2024 | 2024-06-30 | 29.42% | −4.13 pp |
| Q1 2024 | 2024-03-31 | 27.91% | +2.50 pp |
| Q4 2023 | 2023-12-31 | 28.70% | +23.04 pp |
| Q3 2023 | 2023-09-30 | 14.08% | −14.22 pp |
| Q2 2023 | 2023-06-30 | 33.55% | +7.72 pp |
| Q1 2023 | 2023-03-31 | 25.41% | −7.80 pp |
| Q4 2022 | 2022-12-31 | 5.65% | −27.59 pp |
| Q3 2022 | 2022-09-30 | 28.30% | −16.99 pp |
| Q2 2022 | 2022-06-30 | 25.83% | +19.45 pp |
| Q1 2022 | 2022-03-31 | 33.21% | +24.23 pp |
| Q4 2021 | 2021-12-31 | 33.24% | +14.13 pp |
| Q3 2021 | 2021-09-30 | 45.29% | +3.38 pp |
| Q2 2021 | 2021-06-30 | 6.38% | −20.84 pp |
| Q1 2021 | 2021-03-31 | 8.98% | −27.25 pp |
| Q4 2020 | 2020-12-31 | 19.11% | +45.37 pp |
| Q3 2020 | 2020-09-30 | 41.91% | +3.47 pp |
| Q2 2020 | 2020-06-30 | 27.22% | −9.39 pp |
| Q1 2020 | 2020-03-31 | 36.23% | −4.39 pp |
| Q4 2019 | 2019-12-31 | −26.26% | −53.18 pp |
| Q3 2019 | 2019-09-30 | 38.43% | +0.04 pp |
| Q2 2019 | 2019-06-30 | 36.62% | +11.29 pp |
| Q1 2019 | 2019-03-31 | 40.63% | +115.56 pp |
| Q4 2018 | 2018-12-31 | 26.92% | +3.94 pp |
| Q3 2018 | 2018-09-30 | 38.39% | +5.22 pp |
| Q2 2018 | 2018-06-30 | 25.33% | −12.38 pp |
| Q1 2018 | 2018-03-31 | −74.94% | −116.90 pp |
| Q4 2017 | 2017-12-31 | 22.98% | −12.69 pp |
| Q3 2017 | 2017-09-30 | 33.17% | +39.42 pp |
| Q2 2017 | 2017-06-30 | 37.71% | +4.61 pp |
| Q1 2017 | 2017-03-31 | 41.96% | +8.36 pp |
| Q4 2016 | 2016-12-31 | 35.66% | +4.24 pp |
| Q3 2016 | 2016-09-30 | −6.25% | −48.39 pp |
| Q2 2016 | 2016-06-30 | 33.10% | −2.65 pp |
| Q1 2016 | 2016-03-31 | 33.60% | −11.40 pp |
| Q4 2015 | 2015-12-31 | 31.42% | −12.58 pp |
| Q3 2015 | 2015-09-30 | 42.14% | −12.23 pp |
| Q2 2015 | 2015-06-30 | 35.75% | −1.62 pp |
| Q1 2015 | 2015-03-31 | 45.00% | +4.83 pp |
| Q4 2014 | 2014-12-31 | 44.00% | +13.28 pp |
| Q3 2014 | 2014-09-30 | 54.37% | +50.83 pp |
| Q2 2014 | 2014-06-30 | 37.37% | −4.56 pp |
| Q1 2014 | 2014-03-31 | 40.17% | −2.73 pp |
| Q4 2013 | 2013-12-31 | 30.72% | +7.31 pp |
| Q3 2013 | 2013-09-30 | 3.54% | −26.41 pp |
| Q2 2013 | 2013-06-30 | 41.93% | +4.29 pp |
| Q1 2013 | 2013-03-31 | 42.91% | +10.54 pp |
| Q4 2012 | 2012-12-31 | 23.41% | −7.67 pp |
| Q3 2012 | 2012-09-30 | 29.95% | −14.56 pp |
| Q2 2012 | 2012-06-30 | 37.64% | −1.87 pp |
| Q1 2012 | 2012-03-31 | 32.37% | −3.34 pp |
| Q4 2011 | 2011-12-31 | 31.08% | — |
| Q3 2011 | 2011-09-30 | 44.51% | — |
| Q2 2011 | 2011-06-30 | 39.51% | — |
| Q1 2011 | 2011-03-31 | 35.71% | — |
Bausch Health Companies ebitda margin trends
Over the last five fiscal years, Bausch Health Companies's ebitda margin decreased from 31.16% to 29.43%, a change of −1.73 percentage points. The latest reported quarter, Q2 2026, shows 35.80%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bausch Health Companies source filings ↗